Drugs in clinical trials: compassionate use activation procedure
In this time of COVID-19 emergency, one often hears about 'Compassionate Use' The DM 7/9/2017 regulates the free supply by pharmaceutical companies
24 March 2020
In this time of COVID-19 emergency, one often hears about 'Compassionate Use' The DM 7/9/2017 regulates the free supply by pharmaceutical companies
In these quarantine days, Pharma Value wants to share with you some useful content for those working in regulatory and market access and for
Many in the sector have analysed the interministerial decree on the new negotiation criteria published in the Official Journal on 24 July 2020, making the necessary comparisons
